Amid a broader push to beef up cell and gene therapy manufacturing capacity in Europe, Novartis has opened the doors to a €40 ...

Swiss drugmaker Novartis has opened a new viral vector production plant in Menges, central Slovenia, following an investment ...

The Gene Vector Core was founded in 1997 as the Adenovirus Vector Production Core. Over the years, we have extended our expertise to other popular viral vector systems. Our core has been one of BCM ...

Mirus offers solutions to increase process efficiency for viral vector production, and a unique reagent formulation that aims to boost virus quality and functional titres compared to traditional ...

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on ...

Nanoneedle technology offers the capability to simultaneously quantify titers of true, full viral genomes and a range of partial species.

Cell line development plays a pivotal role in the manufacturing of therapeutic proteins, vaccines and other biologics.

Creative Biolabs has expanded the viral vector production lines to enhance strategy and capabilities for genetic disorders and cancer research. SHIRLEY, NY, UNITED STATES, January 27, 2025 ...

To advance its gene-modified cell therapy to clinical stages, Captain T Cell will utilise the plasmid and viral vector ...

OXB (LSE: OXB), a quality and innovation-led cell and gene therapy CDMO, today announces the appointment of Jefferies International Limited ("Jefferies") as its Joint Corporate Broker and Joint ...

At a recent meeting on viral vector purification held in Williamsburg ... Kleinschmidt, J.A. Novel tools for production and purification of recombinant adeno-associated virus vectors.